Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BX Other blood glucose lowering drugs, excl. insulins
A10BX16 Tirzepatide
D11360 Tirzepatide (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Agents
Glucose Control Agents, Other
Tirzepatide
D11360 Tirzepatide (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2499 Others
D11360 Tirzepatide (JAN/USAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
D11360 Tirzepatide
Drug classes [BR:br08332]
Antidiabetic agent
DG01493 GLP-1 receptor agonist
D11360 Tirzepatide
DG02044 Hypoglycemic agent
D11360 Tirzepatide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GLP1R
D11360 Tirzepatide (JAN/USAN) <JP/US>
Gastric inhibitory polypeptide
GIPR
D11360 Tirzepatide (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11360
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11360
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11360
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11360
